[Apex Biotech] May 2026 Revenue Reaches NT$ 146 Million (Down 18.1% YoY)
NQ Score
36/100
N1 Content Completeness
5
AI Summary (NQ-processed)
Apex Biotechnology Corp. announced its May 2026 monthly revenue of NT$ 145.66 million, representing an 18.1% decline compared to the same period last year.
AI Analysis
Frequently Asked Questions
- Q: What is Apex Biotechnology's revenue for May 2026?
- A: The monthly revenue is NT$ 145,664 thousand (approximately NT$ 146 million).
- Q: How did the revenue change compared to the previous year?
- A: It decreased by 18.1% compared to May 2025.
- Q: What is the industry sector of Apex Biotechnology?
- A: It is categorized under the Biotechnology and Medical Care industry.